The establishment of the AAV-α-synuclein model was a major advancement to the field, as it causes α-synuclein overexpression and a gradual neuronal loss [3] that is more representative of the changes occurring in the brains of Parkinson’s disease patients. The gene discussed is SNCA; the disease is Parkinson disease.